Management of polypharmacy in elderly patients with diabetes mellitus
10.3760/cma.j.issn.0254-9026.2025.02.005
- VernacularTitle:老年糖尿病患者多重用药管理
- Author:
Jinqian CHEN
1
;
Jin ZHOU
1
;
Jianbo WANG
1
;
Zhenyu ZHAO
1
Author Information
1. 天津医科大学朱宪彝纪念医院 天津市内分泌研究所 国家卫健委激素与发育重点实验室 天津市代谢性疾病重点实验室，天津 300134
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus, type 2;
Polypharmacy;
Medication therapy management
- From:
Chinese Journal of Geriatrics
2025;44(2):136-140
- CountryChina
- Language:Chinese
-
Abstract:
With the intensification of population aging, type 2 diabetes has emerged as a significant global public health concern, particularly in developing countries.Epidemiological data indicate that the elderly population faces a higher risk of diabetes, accompanied by an increasing incidence rate.Due to the unique pathological characteristics and comorbid chronic diseases prevalent among elderly diabetes patients, polypharmacy is both common and often unavoidable.Inappropriate polypharmacy poses heightened health risks for patients and complicates clinical management, underscoring the urgent need to optimize intervention strategies.Effective approaches include regular medication reviews, adjustments to blood glucose control targets, and the development of personalized deprescribing plans informed by comprehensive geriatric assessments.While some interventions have demonstrated positive effects in reducing potentially inappropriate medications, addressing prescription omissions, and enhancing medication adherence, their capacity to yield significant clinical improvements requires further validation.Future research should prioritize the identification of the most effective interventions for high-risk populations.
